BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 35645120)

  • 1. The role of surgery on locoregional treatment of patients with breast cancer newly diagnosed with ipsilateral supraclavicular lymph node metastasis.
    Liu BW; Chen LX; Ma K; Chi JR; Yang ZJ; Yu Y; Cao XC
    J Cancer Res Ther; 2022 Apr; 18(2):496-502. PubMed ID: 35645120
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The Role of Supraclavicular lymph node dissection in Breast Cancer Patients with Synchronous Ipsilateral Supraclavicular Lymph Node Metastasis].
    Zhang W; Qi XM; Chen AX; Zhang P; Cao XC; Xiao CH
    Zhonghua Zhong Liu Za Zhi; 2017 May; 39(5):374-379. PubMed ID: 28535656
    [No Abstract]   [Full Text] [Related]  

  • 3. Role of aggressive locoregional surgery in treatment strategies for ipsilateral supraclavicular lymph node metastasis of breast cancer: a real-world cohort study.
    Feng K; Xing Z; Dai Q; Cheng H; Wang X
    Front Mol Biosci; 2023; 10():1248410. PubMed ID: 37916188
    [No Abstract]   [Full Text] [Related]  

  • 4. Comparison of supraclavicular surgery plus radiotherapy versus radiotherapy alone in breast cancer patients with synchronous ipsilateral supraclavicular lymph node metastasis: A multicenter retrospective study.
    Song YC; Kong J; Li N; Liu XL; Li XH; Zhu LY; Wang YW; Fang H; Jing H; Tang Y; Li YX; Wang XH; Zhang J; Wang SL
    Radiother Oncol; 2023 Jun; 183():109639. PubMed ID: 36990395
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A retrospective study of different local treatments in breast cancer patients with synchronous ipsilateral supraclavicular lymph node metastasis.
    Chang XZ; Yin J; Sun J; Zhang XH; Cao XC
    J Cancer Res Ther; 2013 Nov; 9 Suppl():S158-61. PubMed ID: 24516053
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of Ipsilateral Supraclavicular Lymph Node Dissection (ISLND) for Breast Cancer Patients and a Nomogram for Predicting Ipsilateral Supraclavicular Pathological Complete Response (ispCR).
    Lv M; Li J; Guo H; Wang C; Tian P; Ma Y; Chen X; Luo S
    Ann Surg Oncol; 2021 Sep; 28(9):5098-5109. PubMed ID: 33598861
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development and validation of a nomogram for predicting survival of breast cancer patients with ipsilateral supraclavicular lymph node metastasis.
    Lyu MH; Ma YZ; Tian PQ; Guo HH; Wang C; Liu ZZ; Chen XC
    Chin Med J (Engl); 2021 Nov; 134(22):2692-2699. PubMed ID: 34743149
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Construction of a nomogram prediction model for pathological complete response (pCR) of ipsilateral supraclavicular lymph node after neoadjuvant chemotherapy for breast cancer with first diagnosis of ipsilateral supraclavicular lymph node metastasis].
    Lyu MH; Jiao DC; Wu JZ; Tian PQ; Ma YZ; Liu ZZ; Chen XC
    Zhonghua Zhong Liu Za Zhi; 2022 Feb; 44(2):160-166. PubMed ID: 35184460
    [No Abstract]   [Full Text] [Related]  

  • 9. [Clinicopathological features and prognostic factors of breast cancer patients with inguinal lymph node metastases: a report of 17 cases].
    Li Q; Xu BH; Zhang P; Li Q; Yuan P; Wang JY; Luo Y; Ma F; Fan Y; Li Q
    Zhonghua Zhong Liu Za Zhi; 2013 Mar; 35(3):207-11. PubMed ID: 23880002
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prediction of supraclavicular lymph node metastasis in breast carcinoma.
    Chen SC; Chen MF; Hwang TL; Chao TC; Lo YF; Hsueh S; Chang JT; Leung WM
    Int J Radiat Oncol Biol Phys; 2002 Mar; 52(3):614-9. PubMed ID: 11849781
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Survival benefit of post-mastectomy radiotherapy in breast carcinoma patients with T1-2 tumor and 1-3 axillary lymph node(s) metastasis.
    Duraker N; Demir D; Bati B; Yilmaz BD; Bati Y; Çaynak ZC; Sobutay E
    Jpn J Clin Oncol; 2012 Jul; 42(7):601-8. PubMed ID: 22511807
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aggressive Surgical Excision of Supraclavicular Lymph Node Did Not Improve the Outcomes of Breast Cancer With Supraclavicular Lymph Node Involvement (KROG 16-14).
    Kim K; Kim SS; Shin KH; Kim JH; Ahn SD; Choi DH; Park W; Lee SY; Chun M; Kim JH; Kim YB; Cha J; Park HJ; Lee DS; Jung W
    Clin Breast Cancer; 2020 Feb; 20(1):51-60. PubMed ID: 31629642
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic factors and the role of primary debulking in operable stage IVB ovarian cancer with supraclavicular lymph node metastasis: a retrospective study in Chinese patients.
    Quan C; Chen X; Wen H; Wu X; Li J
    BMC Cancer; 2024 May; 24(1):565. PubMed ID: 38711015
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Prognosis and risk factors of 1 791 patients with breast cancer treated with breast-conserving surgery based on real-world data].
    Chen SY; Tang Y; Song YW; Wang SL; Jin J; Liu YP; Wang WH; Fang H; Ren H; Sun GY; Wang JY; Jing H; Zhang JH; Liu XF; Yu ZH; Li YX
    Zhonghua Zhong Liu Za Zhi; 2018 Aug; 40(8):619-625. PubMed ID: 30139034
    [No Abstract]   [Full Text] [Related]  

  • 15. Supraclavicular lymph node dissection with radiotherapy versus radiotherapy alone for operable breast cancer with synchronous ipsilateral supraclavicular lymph node metastases: a real-world cohort study.
    Ai X; Wang M; Li J; Hu Y; Hou L; Zheng X; Yan Y; Pan Q; Jin Y; Liu W; Tan X; Tian Y; Zhang Y; Tang P; Jiang J
    Gland Surg; 2020 Apr; 9(2):329-341. PubMed ID: 32420257
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Supraclavicular nodal failure in patients with one to three positive axillary lymph nodes treated with breast conserving surgery and breast irradiation, without supraclavicular node radiation.
    Reddy SG; Kiel KD
    Breast J; 2007; 13(1):12-8. PubMed ID: 17214788
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Locoregional Management and Prognostic Factors in Breast Cancer With Ipsilateral Internal Mammary and Axillary Lymph Node Involvement.
    Andring LM; Diao K; Sun S; Patel M; Whitman GJ; Schlembach P; Arzu I; Joyner MM; Shaitelman SF; Hoffman K; Stauder MC; Smith BD; Woodward WA
    Int J Radiat Oncol Biol Phys; 2022 Jul; 113(3):552-560. PubMed ID: 35248602
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association Between 21-Gene Assay Recurrence Score and Locoregional Recurrence Rates in Patients With Node-Positive Breast Cancer.
    Woodward WA; Barlow WE; Jagsi R; Buchholz TA; Shak S; Baehner F; Whelan TJ; Davidson NE; Ingle JN; King TA; Ravdin PM; Osborne CK; Tripathy D; Livingston RB; Gralow JR; Hortobagyi GN; Hayes DF; Albain KS
    JAMA Oncol; 2020 Apr; 6(4):505-511. PubMed ID: 31917424
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison between surgery plus radiotherapy and radiotherapy alone in treating breast cancer patients with ipsilateral supraclavicular lymph node metastasis.
    Sun XF; Wang YJ; Huang T; Niu LJ; Zhang Q; Liu ZZ
    Gland Surg; 2020 Oct; 9(5):1513-1520. PubMed ID: 33224826
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A clinical study to assess the pathological involvement of occult supraclavicular lymphnode metastasis in case of locally advanced operable breast carcinoma.
    Virani SJ; Patni S; Shah R
    Indian J Cancer; 2015; 52(3):282-5. PubMed ID: 26905111
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.